MedAdvisor share price rockets 15% higher on UK update

The MedAdvisor Ltd (ASX:MDR) share price is rocketing higher on Tuesday morning after providing an update on its UK operations…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MedAdvisor Ltd (ASX: MDR) share price is rocketing higher on Tuesday.

In morning trade the leading digital medication management company's shares are up 15.5% to 33.5 cents.

Why is the MedAdvisor share price rocketing higher?

Investors have been buying the company's shares this morning following the release of an announcement relating to its UK operations.

According to the release, the National Pharmacy Association (NPA) has endorsed the MedAdvisor digital medication management platform as the recommended digital supplier for the UK community pharmacy market.

This is a big positive for the company given that the NPA represent 8 out of 10 of the UK independent pharmacy members. This is a number which exceeds the entire Australian Pharmacy market.

Under the agreement the NPA will promote MedAdvisor's solution to their pharmacy members. MedAdvisor will then provide its pharmacy software PlusOne and the MedAdvisor app to these pharmacies. The NPA will also assist member pharmacies to benefit from Digital Adherence Programs that better support patient health outcomes.

This builds on MedAdvisor's partnership with Day Lewis Pharmacy Group. This is one of the largest independent pharmacy chains in the UK, owning over 270 pharmacies and servicing over 1 million customers.

MedAdvisor's CEO, Robert Read, said: "MedAdvisor has demonstrated the value of connecting patients digitally with community pharmacy. The UK market is a highly attractive market given the size and similarities to the Australian market. The NPA is the leading advisory body to 8 out of 10 independent UK community pharmacies and to have the endorsement of the NPA will really support our efforts to promote MedAdvisor to the UK's independent pharmacy market."

The NPA's acting chair, Andrew Lane, spoke very positively about MedAdvisor.

He said: "We have looked globally for the best solution for pharmacy digital solutions. We were really impressed with what MedAdvisor has delivered in other markets globally and we can see the value that MedAdvisor's tried and tested digital solutions can bring to our member pharmacies. We are passionate about improving medication adherence and this partnership will help us do that in a more impactful way."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended MedAdvisor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »

Female miner smiling at a mine site.
Share Gainers

Up 834% in a year, guess which ASX mining stock is hitting new all-time highs today

The ASX mining stock has gone from strength to strength over the past year.

Read more »